Obesity-linked variants of melanocortin-4 receptor are misfolded in the endoplasmic reticulum and can be rescued to the cell surface by a chemical chaperone.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular Endocrinology

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/me.2010-0071PMID 20631012PMCID PMC2940480
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential of Nonpeptide (Ant)agonists to Rescue Vasopressin V2 Receptor Mutants for the Treatment of X‐linked Nephrogenic Diabetes Insipidus

  2010cited by this paper
• Functional analysis of melanocortin-4-receptor mutants identified in severely obese subjects living in Southern Italy.

  2010cited by this paper
• Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.

  2010cited by this paper
• Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady‐state retention of mutant forms in the proximal golgi

  2009cited by this paper
• Pertussis Toxin-sensitive Signaling of Melanocortin-4 Receptors in Hypothalamic GT1-7 Cells Defines Agouti-related Protein as a Biased Agonist*

  2009cited by this paper
• Endoplasmic reticulum stress plays a central role in development of leptin resistance.

  2009cited by this paper
• Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients

  2009cited by this paper
• Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study.

  2009cited by this paper
• Regulation of GPCRs by endocytic membrane trafficking and its potential implications.

  2008cited by this paper
• Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa.

  2008cited by this paper
• Coordinate Regulation of Phospholipid Biosynthesis and Secretory Pathway Gene Expression in XBP-1(S)-induced Endoplasmic Reticulum Biogenesis*

  2007cited by this paper
• Constitutive Traffic of Melanocortin-4 Receptor in Neuro2A Cells and Immortalized Hypothalamic Neurons*

  2007cited by this paper
• Sequestration of mutated alpha1-antitrypsin into inclusion bodies is a cell-protective mechanism to maintain endoplasmic reticulum function.

  2007cited by this paper
• G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo

  2007cited by this paper
• Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics.

  2007cited by this paper
• Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.

  2007cited by this paper
• Signal integration in the endoplasmic reticulum unfolded protein response

  2007cited by this paper
• IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response

  2007cited by this paper
• Signal sequence mutation in autosomal dominant form of hypoparathyroidism induces apoptosis that is corrected by a chemical chaperone

  2007cited by this paper
• Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating.

  2006cited by this paper
• Peripheral Administration of a Melanocortin 4-Receptor Inverse Agonist Prevents Loss of Lean Body Mass in Tumor-Bearing Mice

  2006cited by this paper
• Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.

  2006cited by this paper
• Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy.

  2005cited by this paper
• Rescue of vasopressin V2 receptor mutants by chemical chaperones: specificity and mechanism.

  2005cited by this paper
• ERAD: the long road to destruction

  2005cited by this paper
• Divergence of melanocortin pathways in the control of food intake and energy expenditure.

  2005cited by this paper
• Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk.

  2005cited by this paper
• Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity.

  2005cited by this paper
• Ubiquitination of G-protein-coupled receptors.

  2004cited by this paper
• Disease‐causing V2 Vasopressin Receptors are Retained in Different Compartments of the Early Secretory Pathway

  2004cited by this paper
• Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins.

  2004cited by this paper
• Identification of 2-[2-[2-(5-bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model.

  2004cited by this paper
• Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity.

  2003cited by this paper
• Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations.

  2003cited by this paper
• The mammalian unfolded protein response.

  2003cited by this paper
• Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms.

  2003cited by this paper
• Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.

  2003cited by this paper
• Poor Cell Surface Expression of Human Melanocortin-4 Receptor Mutations Associated with Obesity*

  2003cited by this paper
• Cell Surface Expression of the Melanocortin-4 Receptor Is Dependent on a C-terminal Di-isoleucine Sequence at Codons 316/317*

  2003cited by this paper
• Molecular Genetics of Human Obesity‐Associated MC4R Mutations

  2003cited by this paper
• Structural basis for recognition of acidic-cluster dileucine sequence by GGA1

  2002cited by this paper
• IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA

  2002cited by this paper
• Adaptor-related proteins.

  2001cited by this paper
• Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity.

  2000cited by this paper
• Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.

  2000cited by this paper
• Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency.

  2000cited by this paper
• Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans.

  1999cited by this paper
• A frameshift mutation in MC4R associated with dominantly inherited human obesity

  1998cited by this paper
• A frameshift mutation in human MC4R is associated with a dominant form of obesity

  1998cited by this paper
• In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.

  1997cited by this paper
• Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

  1997cited by this paper
• The ubiquitin conjugation system is required for ligand‐induced endocytosis and degradation of the growth hormone receptor.

  1996cited by this paper
• Purification and characterization of the human KDEL receptor.

  1996cited by this paper
• Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy.

  1992cited by this paper
• Gonadotropin-releasing hormone neuronal cell lines.

  1992cited by this paper
• Immortalization of hypothalamic GnRH by genetically targeted tumorigenesis

  1990cited by this paper
• Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis.

  1990cited by this paper
• The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins

  1988cited by this paper

• Genetic Insights into Severe Obesity: A Case Study of MC4R Variant Identification and Clinical Implications

  2025cites this paper
• RISING STARS: Targeting G protein-coupled receptors to regulate energy homeostasis

  2023cites this paper
• Functional Characterization of Novel MC4R Variants Identified in Two Unrelated Patients with Morbid Obesity in Qatar

  2023cites this paper
• Novel melanocortin-3 and -4 receptor functional variants in Asian children with severe obesity.

  2023cites this paper
• Lipocalin 2 – mutation screen and serum levels in patients with anorexia nervosa or obesity and in lean individuals

  2023cites this paper
• Liraglutide Counteracts Endoplasmic Reticulum Stress in Palmitate-Treated Hypothalamic Neurons without Restoring Mitochondrial Homeostasis

  2022cites this paper
• Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation

  2021cites this paper
• Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta.

  2021cites this paper
• Thyrotropin Receptor p.N432D Retained Variant Is Degraded Through an Alternative Lysosomal/Autophagosomal Pathway and Can Be Functionally Rescued by Chemical Chaperones

  2021cites this paper
• Melanocortin‐4 receptor complexity in energy homeostasis,obesity and drug development strategies

  2021cites this paper
• Functional Characterization of the Obesity-Linked Variant of the β3-Adrenergic Receptor

  2021cites this paper
• GPCR's and Endocrinology

  2021cites this paper
• Molecular chaperones and G protein-coupled receptor maturation and pharmacology.

  2020cites this paper
• Delivery of phosphatidylethanolamine blunts stress in hepatoma cells exposed to elevated palmitate by targeting the endoplasmic reticulum

  2020cites this paper
• Therapeutic strategies for diseases caused by loss-of-function mutations in G protein-coupled receptors.

  2019cites this paper
• Single cell analysis of β2-Adrenergic receptor dynamics by quantitative fluorescence Microscopy.

  2019cites this paper
• The melanocortin pathway and control of appetite-progress and therapeutic implications.

  2019cites this paper
• Glucose-regulated protein 78 binds to and regulates the melanocortin-4 receptor

  2018cites this paper
• Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.

  2018cites this paper
• Genetic variants help define the role of the MC4R C-terminus in signaling and cell surface stability

  2018cites this paper
• Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency

  2017cites this paper
• Cell surface targeting of the Melanocortin 5 Receptor (MC5R) requires serine-rich terminal motifs.

  2017cites this paper
• Pharmacological chaperones for the misfolded melanocortin-4 receptor associated with human obesity.

  2017cites this paper
• Pharmacological characterization and functional rescue of the giant panda and human melanocortin-4 receptors

  2017cites this paper
• Leptin signalling pathways in hypothalamic neurons

  2016cites this paper
• Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules.

  2016cites this paper
• Latest approaches for the treatment of obesity

  2015cites this paper
• Phenylbutyric Acid: simple structure - multiple effects.

  2015cites this paper
• hMRAPα, but Not hMRAP2, Enhances hMC4R Constitutive Activity in HEK293 Cells and This Is Not Dependent on hMRAPα Induced Changes in hMC4R Complex N-linked Glycosylation

  2015cites this paper
• The Role of Leptin-Melanocortin System Gene Variants in Antipsychotic-Induced Weight Gain

  2015cites this paper
• Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin.

  2015cites this paper
• Associations between a common variant near the MC4R gene and serum triglyceride levels in an obese pediatric cohort

  2015cites this paper
• Pharmacological characterization and functional rescue of human melanocortin-4 receptor mutants

  2014influential citation
• Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

  2014cites this paper
• Mild lipid stress induces profound loss of MC4R protein abundance and function.

  2014cites this paper
• Rescue of the mutant MC4R cell surface expression and signaling by a novel 1

  2014cites this paper
• Constitutive activity in melanocortin-4 receptor: biased signaling of inverse agonists.

  2014cites this paper
• A Small Molecule Agonist THIQ as a Novel Pharmacoperone for Intracellularly Retained Melanocortin-4 Receptor Mutants

  2014cites this paper
• A Naturally Occurring GIP Receptor Variant Undergoes Enhanced Agonist-Induced Desensitization, Which Impairs GIP Control of Adipose Insulin Sensitivity

  2014cites this paper
• Ipsen 5i is a Novel Potent Pharmacoperone for Intracellularly Retained Melanocortin-4 Receptor Mutants

  2014cites this paper
• The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options

  2014cites this paper
• Rescue of defective MC4R cell-surface expression and signaling by a novel pharmacoperone Ipsen 17.

  2014influential citation
• Exposure of MC4R to agonist in the endoplasmic reticulum stabilizes an active conformation of the receptor that does not desensitize

  2013cites this paper
• Structural determinants regulating cell surface targeting of melanocortin receptors.

  2013cites this paper
• Functional Rescue of Obesity-causing Human Melanocortin-4 Receptor Mutants: Insights for Pharmacological Chaperon Drugs

  2013cites this paper
• Melanocortin-4 receptor in energy homeostasis and obesity pathogenesis.

  2013cites this paper
• The Genetic Basis Of Type 2 Diabetes: The Role Of Sel1L In Glucose And Energy Homeostasis

  2013cites this paper
• Bioanalysis of eukaryotic organelles.

  2013cites this paper
• Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene

  2012cites this paper
• Endoplasmic reticulum stress, obesity and diabetes.

  2012cites this paper
• Conséquences fonctionnelles de mutations affectant le récepteur de la vasopressine de type 2 et implications thérapeutiques

  2012cites this paper
• A Novel Melanocortin-4 Receptor Mutation MC4R-P272L Associated with Severe Obesity Has Increased Propensity To Be Ubiquitinated in the ER in the Face of Correct Folding

  2012cites this paper
• Pathomechanistic characterization of two exonic L1CAM variants located in trans in an obligate carrier of X-linked hydrocephalus

  2012cites this paper
• GPCR Signalling Complexes – Synthesis, Assembly, Trafficking and Specificity

  2012cites this paper
• Constitutive Cholesterol-dependent Endocytosis of Melanocortin-4 Receptor (MC4R) Is Essential to Maintain Receptor Responsiveness to α-Melanocyte-stimulating Hormone (α-MSH)*

  2012cites this paper
• Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target.

  2012cites this paper
• Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

  2011cites this paper
• Effect of Voluntary Exercise and Diet on the Unfolded Protein Response in the Brain of Mice

  2011cites this paper
• The cytosolic chaperone Hsc70 promotes traffic to the cell surface of intracellular retained melanocortin-4 receptor mutants.

  2011influential citation
• G protein-coupled receptors: mutations and endocrine diseases

  2011cites this paper
• β-catenin is a molecular switch that regulates transition of cell-cell adhesion to fusion

  2011cites this paper
• Functional studies on twenty novel naturally occurring melanocortin-4 receptor mutations.

  2011cites this paper
• Obesity Drug Update: The Lost Decade?

  2010cites this paper